A case report of malignant struma ovarii with papillary thyroid carcinoma.

Autor: Rahimi Y; University of Southern California Los Angeles California USA., Rabizadeh S; Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital Tehran University of Medical Sciences Tehran Iran., Seifouri S; Guy's Hospital London UK., Seifouri K; Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital Tehran University of Medical Sciences Tehran Iran., Salarvand S; Department of pathology Cancer Institute Tehran University of Medical Sciences Tehran Iran., Nakhjavani M; Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital Tehran University of Medical Sciences Tehran Iran.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2024 Apr 12; Vol. 12 (4), pp. e8610. Date of Electronic Publication: 2024 Apr 12 (Print Publication: 2024).
DOI: 10.1002/ccr3.8610
Abstrakt: Key Clinical Message: Struma ovarii (SO), is a rare and specialized ovarian teratoma. The treatment is controversial depending on the risk of recurrence and metastasis. Here a SO with papillary thyroid carcinoma is reported and the approach is thoroughly discussed.
Abstract: Struma ovarii (SO) is a highly specialized ovarian teratoma primarily composed of thyroid tissue. Clinical features associated with SO include lower abdominal discomfort, unusual vaginal bleeding, ascites, and hyperthyroidism. While SO rarely transforms into malignancy, the optimal degree of treatment remains controversial due to the varying risks of recurrence and metastasis. In this report, we present the case of a 64-year-old woman experiencing abdominal pain and diagnosed with SO, accompanied by papillary thyroid carcinoma. We thoroughly discuss the evaluation and management of this rare condition.
Competing Interests: The authors confirm that there is no conflict of interest.
(© 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje